(Q30300395)

English

Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434 (English)

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

T-cell acute lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Kimberly P Dunsmore

object named as

Kimberly P Dunsmore

2

0 references

Stephen P Hunger

16

object named as

Stephen P Hunger

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

11

object named as

Nyla A Heerema

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Julie Gastier-Foster

9

object named as

Julie M Gastier-Foster

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Meenakshi Devidas

3

object named as

Meenakshi Devidas

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

12

object named as

Mignon L Loh

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

14

object named as

Naomi J Winick

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

author name string

Stuart S Winter

1

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Nancy Eisenberg

4

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Barbara L Asselin

5

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Brent L Wood

6

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Marcia S Leonard Rn

7

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

John Murphy

8

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Andrew J Carroll

10

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Elizabeth A Raetz

13

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

William L Carroll

15

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

publication date

8 March 2015

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

62

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

7

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

1176-1183

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Treating childhood acute lymphoblastic leukemia without cranial irradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Nelarabine: a novel purine antimetabolite antineoplastic agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Treatment of acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Clinicopathologic aspects of E rosette negative T cell acute lymphocytic leukemia: a Pediatric Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

3 June 2018

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.25470

21 January 2018

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.25470

21 January 2018

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.25470

21 January 2018

Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.25470

21 January 2018

Mechanisms for T-cell selective cytotoxicity of arabinosylguanine

1 reference

https://api.crossref.org/works/10.1002%2FPBC.25470

21 January 2018

Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.25470

21 January 2018

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.25470

21 January 2018

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

26 November 2018

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433576

26 November 2018

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25755211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25755211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25755211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25755211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal antibody blocking human T cell function

1 reference

https://pubmed.ncbi.nlm.nih.gov/25755211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/25755211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Childhood T-all: it's time to move on

1 reference

https://pubmed.ncbi.nlm.nih.gov/25755211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PBC.25470

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

release_6smqddm5fjch3nyhifqinfugby

1 reference

https://api.fatcat.wiki/v0/release/6smqddm5fjch3nyhifqinfugby

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30300395&oldid=1954648685"